Syntheses of carbon‐14 labelled AJ‐9677, a specific β 3 ‐adrenoceptor agonist
Two 14 C‐labelled versions of AJ‐9677, a novel anti‐diabetic drug candidate, have been synthesized. The first, [acetic acid‐2‐ 14 C]AJ‐9677, was synthesized via a four‐step process starting from 2‐chloro‐ N,N ‐diethyl[2‐ 14 C]acetamide ( 3 ), and the second, [hydroxymethine‐ 14 C]AJ‐9677, by a two s...
Gespeichert in:
Veröffentlicht in: | Journal of labelled compounds & radiopharmaceuticals 2004-05, Vol.47 (6), p.349-357 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Two
14
C‐labelled versions of AJ‐9677, a novel anti‐diabetic drug candidate, have been synthesized. The first, [acetic acid‐2‐
14
C]AJ‐9677, was synthesized via a four‐step process starting from 2‐chloro‐
N,N
‐diethyl[2‐
14
C]acetamide (
3
), and the second, [hydroxymethine‐
14
C]AJ‐9677, by a two step process from (
R
)‐3‐chloro[7‐
14
C]styrene oxide (
8
). When stored in the solid state both compounds undergo radiolytic decomposition in a similar manner, despite the labelled position being different, to give the dechlorinated derivative (
12a, 12b
). Purification of the required product was achieved after derivatization to the methyl esters. Copyright © 2004 John Wiley & Sons, Ltd. |
---|---|
ISSN: | 0362-4803 1099-1344 |
DOI: | 10.1002/jlcr.821 |